TrialBMC infectious diseases2022

Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study.

Manuel Rojas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.